Does Rosuvastatin/Ezetimibe Combination Therapy Offer Potential Benefits for Glucose Metabolism beyond Lipid-Lowering Efficacy in T2DM?

Authors :: Park IR
Moon JS
Source :: Diabetes & metabolism journal [Diabetes Metab J] 2024 May; Vol. 48 (3), pp. 387-389. Date of Electronic Publication: 2024 May 22.
Publication Year :: 2024

Subjects :: Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use
Hydroxymethylglutaryl-CoA Reductase Inhibitors administration & dosage
Blood Glucose analysis
Azetidines therapeutic use
Azetidines administration & dosage
Sulfonamides therapeutic use
Sulfonamides administration & dosage
Pyrimidines therapeutic use
Pyrimidines administration & dosage
Rosuvastatin Calcium therapeutic use
Rosuvastatin Calcium administration & dosage
Diabetes Mellitus, Type 2 drug therapy
Ezetimibe therapeutic use
Ezetimibe administration & dosage
Anticholesteremic Agents therapeutic use
Anticholesteremic Agents administration & dosage
Drug Therapy, Combination

Full Text Access

Tools